1. Home
  2. TRDA vs JILL Comparison

TRDA vs JILL Comparison

Compare TRDA & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$6.95

Market Cap

268.6M

Sector

Health Care

ML Signal

HOLD

Logo J. Jill Inc.

JILL

J. Jill Inc.

HOLD

Current Price

$19.75

Market Cap

246.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
JILL
Founded
2016
1959
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
268.6M
246.5M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
TRDA
JILL
Price
$6.95
$19.75
Analyst Decision
Strong Buy
Buy
Analyst Count
3
4
Target Price
$21.00
$17.00
AVG Volume (30 Days)
299.4K
51.3K
Earning Date
05-08-2026
06-10-2026
Dividend Yield
N/A
2.42%
EPS Growth
N/A
N/A
EPS
N/A
0.31
Revenue
$25,421,000.00
$596,549,000.00
Revenue This Year
$39.97
$2.65
Revenue Next Year
$50.80
N/A
P/E Ratio
N/A
$63.97
Revenue Growth
N/A
N/A
52 Week Low
$5.02
$10.41
52 Week High
$16.45
$20.89

Technical Indicators

Market Signals
Indicator
TRDA
JILL
Relative Strength Index (RSI) 49.66 60.83
Support Level $5.71 $15.40
Resistance Level $7.95 N/A
Average True Range (ATR) 0.41 0.80
MACD -0.03 -0.09
Stochastic Oscillator 37.37 56.58

Price Performance

Historical Comparison
TRDA
JILL

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About JILL J. Jill Inc.

J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). J.Jill caters to a distinctive set of women, typically forty-five years and older, offering them various apparel products, footwear, and accessories, comprising shirts, dresses, tops and tees, sweaters, pants and jeans, jewelry, bags, belts, shoes, scarves, etc. The company's operating segments consist of its Retail channels, which derive maximum revenue, and Direct channels. Geographically, the majority of its revenue is derived from the United States.

Share on Social Networks: